SPRO   $1.35  0.75% Market Closed After Close 1.3692 1.42%

Spero Therapeutics Inc
Total Cash 63.53M
totalCashPerShare 1.175
EBITDA 21.01M
Total Debt 4.94M
quickRatio 2.608
currentRatio 2.678
Total Revenue 118.46M
debtToEquity 6.134
Revenue/Share 2.223
ROA 0.104820006
ROE 0.25805
grossProfits
freeCashflow 1.48M
operatingCashflow -14.38M
earningsGrowth
revenueGrowth 2.754
grossMargins 0.37523997
ebitdaMargins 0.17733999
operatingMargins -1.86928
profitMargins 0.14735
enterpriseValue 15.46M
forwardPE -1.0300752
floatShares 40.47M
sharesOutstanding 54.05M
sharesShort 409.11K
sharesShortPriorMonth 355.91K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.20%
heldPercentInstitutions 0.26%
Short Ratio help_outline 3.05%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 1.49
Price To Book help_outline 0.92
earningsQuarterlyGrowth
netIncomeToCommon 17.45M
trailingEps 0.34%
forwardEps -1.33%
enterpriseToEbitda 0.74
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.5 3Q 2024
institutionsCount 59
lastUpdated Sept. 16, 2024, 11:26 a.m.